Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers-Reference-Cited by-同舟云学术

Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers

Published:2018-07-25 Issue:8 Volume:7 Page:844-859
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Adeloye Temitope¹,Sahgal Omair¹,Puri Adeep¹,Warrington Steve¹,Endo Takamasa²,Dennison Jeremy¹,Johnston Atholl³

Affiliation:

1. Hammersmith Medicines Research; London England

2. Maruho Co Ltd; Kyoto Japan

3. Analytical Services International; St George's University of London; London England

Funder

Maruho

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.586/fullpdf

Reference16 articles.

1. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2;Chono;J Antimicrob Chemother,2010

2. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections;Perry;Drugs,1996

3. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients;Levin;Clin Infect Dis,2004

4. The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine;Topletz;Drug Metab Dispos,2013

5. Food and Drug Administration Center for Drug Evaluation and Research (CDER) Guidance for Industry: Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations 2012 46 47

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disproportionality Analysis of Amenamevir-Induced Encephalopathy Using the Japanese Adverse Drug Event Report Database 1;Journal of Infection and Chemotherapy;2024-09

2. Safe Co-Administration of Amenamevir with Calcineurin Inhibitors: Case Reports;BPB Reports;2023

3. Adverse effects of cytochrome P450 induction by amenamevir in an elderly man with herpes zoster;Psychogeriatrics;2022-11-20

4. Polymorphism of CYP3A4*1G gene as a predictor of the hepatotoxicity of antituberculosis therapy;Medicni perspektivi;2022-03-30

5. Novel Bruton’s Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling;Clinical and Translational Science;2021-08-25